Pulmatrix, Inc. (NASDAQ:PULM) Short Interest Update

by · The Cerbat Gem

Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 6,500 shares, an increase of 27.5% from the September 30th total of 5,100 shares. Based on an average trading volume of 11,300 shares, the days-to-cover ratio is presently 0.6 days. Approximately 0.2% of the company’s stock are sold short.

Pulmatrix Stock Performance

Shares of PULM stock remained flat at $2.18 during mid-day trading on Wednesday. 29,549 shares of the company’s stock traded hands, compared to its average volume of 13,556. Pulmatrix has a 1-year low of $1.55 and a 1-year high of $2.75. The stock has a market capitalization of $7.96 million, a PE ratio of -0.89 and a beta of 1.00. The stock’s 50-day moving average price is $2.06 and its two-hundred day moving average price is $2.03.

Pulmatrix (NASDAQ:PULM – Get Free Report) last released its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.87) EPS for the quarter. Pulmatrix had a negative return on equity of 46.86% and a negative net margin of 95.18%. The company had revenue of $1.55 million during the quarter.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on shares of Pulmatrix in a research note on Friday, October 25th. They issued a “hold” rating for the company.

Read Our Latest Stock Analysis on PULM

Pulmatrix Company Profile

(Get Free Report)

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.

Featured Stories